Ignite Creation Date:
2025-12-26 @ 10:36 AM
Ignite Modification Date:
2025-12-31 @ 11:01 AM
Study NCT ID:
NCT04045028
Status:
TERMINATED
Last Update Posted:
2023-04-07
First Post:
2019-07-22
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), Pharmacodynamics (PD), and Preliminary Activity of Tiragolumab in Participants With Relapsed or Refractory Multiple Myeloma or With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma
Sponsor:
Genentech, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-07-22
Start Date Type:
ACTUAL
Primary Completion Date:
2023-03-28
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-03-28
Completion Date Type:
ACTUAL
First Submit Date:
2019-07-22
First Submit QC Date:
None
Study First Post Date:
2019-08-05
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-04-06
Last Update Post Date:
2023-04-07
Last Update Post Date Type:
ACTUAL